Table 2.
Multivariable analysis for positive screen or biopsy of melanoma, non-melanoma skin cancer, and any skin cancer
| Positive screen | Positive biopsy | |||
|---|---|---|---|---|
| Relative Risk (95% CI) | p-value | Relative Risk (95% CI) | p-value | |
| Melanoma* | ||||
| Male Sex | 1.35 (0.98–1.86) | 0.06 | Not selected | |
| Age (years) | 1.02 (1.01–1.03) | < 0.001 | 1.04 (1.03–1.05) | < 0.001 |
| Personal history of melanoma | 1.93 (1.27–2.92) | < 0.01 | Not selected | |
| Non-melanoma skin cancer* | ||||
| Male sex | 1.91 (1.77–2.08) | < 0.001 | 1.47 (1.33–1.62) | < 0.001 |
| Age (years) | 1.04 (1.04–1.05) | < 0.001 | 1.01 (1.01–1.02) | < 0.001 |
| Personal history of any skin cancer | 1.30 (1.20–1.41) | < 0.001 | 1.36 (1.23–1.50) | < 0.001 |
| Any skin cancer* | ||||
| Male Sex | 1.88 (1.74–2.03) | < 0.001 | 1.60 (1.45–1.75) | < 0.001 |
| Age (years) | 1.04 (1.04–1.04) | < 0.001 | 1.04 (1.03–1.04) | < 0.001 |
| Personal history of any skin cancer | 1.26(1.17–1.37) | < 0.001 | 1.43 (1.30–1.58) | < 0.001 |
Significant covariates remaining after multivariable stepwise regression. Stepwise models orginally included hypothesis driven covariates of age, sex, and personal history of skin cancer and melanoma, with stepwise p-value cut off <0.05